BookNathan D. Wong, Ezra A. Amsterdam, Peter P. Toth, editors.
Contents:
Intro
Foreword
References
Preface
Acknowledgements
Contents
Contributors
Focus on Cardiovascular Health Promotion and Disease Prevention: Opportunities for Improvement
1 Introduction
2 Defining Cardiovascular Health
3 Bucket 1: Traditional Clinical Prevention
3.1 Improvement in Utilization and Adherence to Guideline-Recommended Therapies
3.2 Improving Utilization of Cardiac Rehabilitation
3.3 Improving Identification and Treatment of Familial Hypercholesterolemia
4 Bucket 2: Innovative Clinical Prevention
4.1 New Care Models 4.2 Improving Risk Assessment and Treatment of Cardiovascular Disease
4.3 Improving Partnerships and the Use of Registries
5 Bucket 3: Community-Wide Prevention
5.1 Public Policy
5.2 Public Health Initiatives
5.3 Mass Media Campaigns
5.4 Environmental Interventions
5.5 School-Based Interventions
5.6 Workplace Interventions
6 Conclusion
References
National and Global Trends of Cardiovascular Disease Mortality, Morbidity, and Risk
1 Introduction
2 Overall Cardiovascular Disease Mortality and Morbidity
2.1 Cardiovascular Disease Mortality 2.2 Cardiovascular Disease Morbidity
3 Mortality and Morbidity Attributable to CVD Subtypes in the USA
3.1 Coronary Heart Disease
3.2 Stroke and Transient Ischemic Attack
3.3 Heart Failure
3.4 Hypertension
3.5 Other Cardiovascular Disease
4 Prevalence of Ideal Cardiovascular Health Factor Levels
5 Global Burden of Cardiovascular Disease
6 Conclusion
References
Cardiovascular Risk Assessment: From Global Risk Scoring to Risk Enhancing Factors
1 Introduction
2 The High-Risk Approach and Shifting Toward Risk Assessment Equations 2.1 Shifting from Risk Factors to Multivariable Risk Assessment Models
3 Using the Pooled Cohort Equations to Assess Cardiovascular Risk
4 Limitations of the Pooled Cohort Equation
4.1 Populations with Lower or Higher CVD Incidence Rates
4.2 Young Populations and When to Assess Long-Term or Lifetime Risk
4.3 Risk Assessment in Elderly Populations
5 Using Risk Enhancing Factors to Calibrate Risk Assessment
6 Alternative Tools for Risk Assessment
7 Risk Factors Not Represented in Risk Assessment Tools
8 Summary of the ACC/AHA and ESC Guidelines 8.1 ACC/AHA 2019 Primary Prevention Guidelines
8.2 ESC 2016 Cardiovascular Disease Prevention Guidelines
9 Conclusion
References
Assessment and Management of Psychosocial Risk Factors Within Preventive Cardiology Practice
1 Introduction
2 Psychosocial Risk Factors
2.1 Depression
2.2 Anxiety Syndromes
2.3 Lack of Social Connectivity
2.4 Pessimism
2.5 Hostility
2.6 Other Negative Cognitive States
2.7 Lack of Life Purpose
2.8 Vitality Exhaustion
2.9 Chronic Stress
3 Positive Psychosocial Functioning
4 Pathophysiological Mechanisms 5 Management of Psychosocial Risk Factors in Preventive Cardiology.